Phase II Trial of Anti-Epidermal Growth Factor Receptor Radioimmunotherapy in the Treatment of Anaplastic Astrocytoma

Journal of Radiation Oncology - United States
doi 10.1007/s13566-012-0071-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

PLoS ONE
Multidisciplinary
2016English

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

Cetuximab and Platinum-Based Chemoradio- Or Chemotherapy of Patients With Epidermal Growth Factor Receptor Expressing Adenoid Cystic Carcinoma: A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2013English

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Anaplastic Astrocytoma

2020English

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy